Oscar Health, Inc. (OSCR) Stock Forecast
OSCR analyst forecast
as of October 18, 2026- Analyst consensus
- Hold 3.18 / 5 from 11 analysts
- Price target
- $36.40 average of analyst targets
- Upside to target
- +14.1% from the latest close
- Next earnings
- November 5, 2026 EPS estimate $-0.11
- 52-week range
- $10.85 – $34.32
OSCR analyst ratings
11 analystsNumber of analysts at each rating.
OSCR price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
OSCR earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.17 | −$0.40 | $0.07 | −$0.53 | +67.3% | 7 |
| Current fiscal year (2026) | $1.94 | $1.80 | $2.12 | −$1.69 | +215.0% | 8 |
| Next fiscal year (2027) | $2.22 | $2.00 | $2.35 | $1.94 | +14.3% | 8 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
OSCR revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $4.72B | $4.49B | $4.88B | +58.0% | 9 |
| Current fiscal year (2026) | $18.73B | $18.38B | $18.85B | +60.1% | 10 |
| Next fiscal year (2027) | $20.78B | $16.81B | $22.56B | +10.9% | 10 |
OSCR EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
OSCR revenue: reported and forecast
OSCR EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.20 | −$0.25 | −$0.25 | −$0.17 | −$0.17 | −15.0% | 4 up · 0 down |
| Current fiscal year (2026) | $1.06 | $1.75 | $1.75 | $1.91 | $1.94 | +82.8% | 5 up · 0 down |
| Next fiscal year (2027) | $1.49 | $1.88 | $1.88 | $2.17 | $2.22 | +49.1% | 6 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
OSCR earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; OSCR beat in 8 of 12.
What analysts expect from OSCR
11 analysts cover Oscar Health; their consensus rating is hold (3.18 on a 1–5 scale, where 5 is a strong buy). The average price target is $36.40, 14.1% above the latest close of $31.89. Analysts expect earnings of $1.94 per share for 2026, +215.0% from a year earlier. For 2027 the average estimate is $2.22 per share on revenue of $20.8 billion. Oscar Health beat the EPS estimate in 8 of the last 12 quarters.
Related: OSCR income statement, OSCR key metrics, OSCR chart. See the OSCR stock overview for the latest quote and news.
OSCR forecast FAQ
What is Oscar Health's price target?
The average analyst price target for Oscar Health is $36.40, 14.1% above the latest close of $31.89.
Is Oscar Health a buy, hold or sell?
Of 11 analysts covering Oscar Health, 0 rate it a strong buy, 3 a buy, 7 a hold, 1 a sell and 0 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.
What is Oscar Health's EPS forecast?
Analysts forecast $1.94 per share for 2026 (range $1.80 to $2.12); for 2027 the estimate is $2.22.
What is Oscar Health's revenue forecast?
The average revenue estimate for 2026 is $18.7 billion, growth of 60.1%; for 2027 it is $20.8 billion.
When does Oscar Health report earnings?
Oscar Health is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 before the market opens; the EPS estimate is $-0.11.
Does Oscar Health usually beat earnings estimates?
Oscar Health reported EPS at or above the analyst estimate in 8 of the last 12 quarters.